Octapharma USA, Inc.
Chad Andersen has extensive experience in the biotechnology and pharmaceutical industries, primarily with Octapharma USA, Inc., where tenure began in February 2010 and includes progressively advanced roles such as Senior Regional Director for Key Accounts across various regions and Senior Director of Coagulation Sales in the Central Region. Prior to this, Chad served as a Territory Manager at Kedrion S.p.A. and I-Flow Corporation, as well as a Biological Account Executive at Bayer HealthCare/Talecris Biotherapeutics. Educationally, Chad holds a Bachelor’s Degree in Business Administration and Management, with a focus on Economics, from the University of South Dakota, earned between 1985 and 1989.
This person is not in any teams
Octapharma USA, Inc.
1 followers
Octapharma USA, headquartered in Paramus, N.J., is a subsidiary of Octapharma AG, a global human protein products powerhouse, dedicated to the research and manufacture of human proteins. We have been committed to patient care and medical innovation for 40 years. Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. Since being established in 1983, Octapharma is a global healthcare company headquartered in Lachen, Switzerland. Our products are available in 118 countries and reach hundreds of thousands of patients every year.